GLP-1 Safety in RA So far, GLP-1 receptor agonists appear to be generally safe in people with RA, though more research is needed, says Nancy Lane, MD, an endowed professor of medicine, rheumatology, and aging research at the University of California in Davis
In clinical trials, retatrutide has been administered as a subcutaneous injection meaning it is injected into the fatty tissue just beneath the skin once weekly
However, due to concerns for safety, quality, and effectiveness of compounded GLP1RAs, the American Diabetes Association (ADA) has issued guidance recommending switching individuals to different FDA-approved medications to achieve and maintain individualized glucose-lowering, weight management, and/or cardiovascular and kidney risk reduction goals when supply or access is limited [75]
However, many additional factors may affect the rate at which you experience weight loss
(CMS) Formularies and plan differences: Even when Medicare can cover, which Part D plan you have makes a big difference
[DOI] [PubMed] [Google Scholar] 28.Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials
